Australian Sickle Cell Disease Market Assessment

Australian Sickle Cell Disease Market Assessment

Sickle Cell Disease (SCD) is a group of rare blood disorders that is inherited in an autosomal recessive manner. Our report lays focus on the market for this disease in Australia.

Australian Sickle Cell Disease (SCD) market size was estimated to be $1.1 Mn in 2022 and is projected to reach $2.6 Mn by 2030, exhibiting a CAGR of 11% during the forecast period.

To know more check out our: Australian Sickle Cell Disease Market Assessment Analysis 2022 to 2030



subscribe to our newsletter
up